Risk of Acute Kidney Injury in Patients Treated With Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.19-00137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Acute Kidney Injury in Pediatric Patients Treated With Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-Center Study

Cureus
2020English

Acute Kidney Injury in Non-Intensive Care Unit and Intensive Care Unit Patients Treated With Vancomycin and Piperacillin-Tazobactam

Journal of Nippon Medical School
Medicine
2019English

Development of Acute Kidney Injury With Concomitant Use of Vancomycin and Piperacillin-Tazobactam. A Review of Recent Literature

American Journal of Hospital Medicine
2017English

Frequency of Acute Kidney Injury Caused by Tazobactam/Piperacillin in Patients With Pneumonia and Chronic Kidney Disease: A Retrospective Observational Study

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2017English

Co-Administration of Vancomycin and Piperacillin-Tazobactam Is Associated With Increased Renal Dysfunction in Adult and Pediatric Burn Patients

Critical Care
Critical CareIntensive Care Medicine
2017English

Vancomycin Induced Acute Kidney Injury: A Review of the Literature

The Southwest Respiratory and Critical Care Chronicles
2016English

Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin

Cureus
2017English

Vancomycin-Associated Acute Kidney Injury in Hong Kong in 2012–2016

BMC Nephrology
Nephrology
2020English

Incidence and Risk Factors for Early Acute Kidney Injury in Nonsurgical Patients: A Cohort Study

International Journal of Nephrology
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy